Radical cystectomy (RC) is the standard treatment for patients with muscle-invasive bladder cancer, and it is also a valid option for selected patients with high-grade non– muscle-invasive bladder cancer, either as a primary treatment modality or for recurrent or refractory tumours after bladder-conserving regimens [1]. Radical cystectomy entails simultaneous surgery on the urinary tract, intes- tines, and lymph nodes; hence, complications frequently occur after this extensive procedure. According to the literature, the incidence of such secondary conditions varies widely (from 19% to 64%) [2,3], which is probably largely due to disparate definitions of morbidity and to case mix rather than to actual differences. Still, it is essential to consider the whole spectrum of complications, including minor problems as well as perioperative mortality, when